The Child with a Hematological Alteration Flashcards

1
Q

Hematologic System - Hematology

* Study of blood and blood-forming tissues

* Hematopoiesis occurs initially in ___ of all bones
> Stem cells
- Red blood cells (RBC)/erythrocytes
- White blood cells (WBC)/leukocytes
- Platelets

A

bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Red Blood Cells (RBCs) or Erythrocytes

* Biconcave
* Transport O2 to tissue
* Need hemoglobin (Hgb) for O2 transport
* Hemoglobin needs IRON (Fe)

* Production stimulated by decreased circulating O2

* Kidneys secrete ___

* RBC precursors produced in bone marrow

A

erythropoietin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Red Blood Cells (RBCs)

Average size RBCs = ___

  • Macrocytic
  • Microcytic
  • Normocytic
A

MCV (mean corpuscular volume)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Red Blood Cells (RBCs)

Average amount of Hgb in RBCs = ability to transport O2 into cells = ___

  • Hypochromic
  • Normochromic
A

MCH (mean corpuscular hemoglobin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Red Blood Cells (RBCs)

Average amount of Hgb per volume of RBCs (concentration/ratio) of Hgb in RBCs (amount of Hgb small r/t RBC size) = ___

A

MCHC (mean corpuscular hemoglobin concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Red Blood Cells (RBCs)

Anemia occurs:

↓ # RBCs

↓ Hgb content

↓ volume packed RBCs

A

Anemia classified according to:

↓ MCV (size of RBCs)

↓ MCH (amount Hgb in RBCs)

↓ MCHC (concentration of Hgb in RBCs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

?

↑ # RBCs

A

Polycythemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

White Blood Cells (WBCs) or Leukocytes

* Produced in bone marrow and lymphatic tissue

Protect body by:

  • Phagocytosis
  • Production of antibodies

Disorders of WBCs:

  • Rate of WBC production = lymphocytosis or lymphopenia
  • Alteration in cell function
A

Types of WBCs

Granulocytes

  • Neutrophils
  • Eosinophils
  • Basophils

Agranulocytes

  • Monocytes/macrophages
  • Lymphocytes
  • T-cells
  • B-cells
  • Natural Killer (NK) cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Platelets

* Promote hemostasis
* Bone marrow - ?
* Smaller fragmented cells - ?

* Disorders occur when bone marrow cannot produce for demand

A

Megakaryocytes

Platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

?

Most common cause of anemia in children

Causes
- ↓ Fe intake

  • ↑ Fe or blood loss
  • Rapid growth rate

Diagnostic Evaluation
* Nutritional assessment
* Laboratory work-up
> CBC
- Hgb, MCV, MCH ↓
- Reticulocyte count - normal or ↑
- Serum ferritin and serum Fe ↓
- TIBC ↑

A

Iron deficiency anemia (IDA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Iron deficiency anemia (IDA) - Manifestations

* Extreme pallor
* Pale mucous membranes and conjunctiva
* Tachycardia, tachypnea, lethargy, fatigue, irritability

A

Therapeutic regimen
> Dietary changes
- Iron-rich foods
- Vitamin C (increases iron absorption)

> Iron supplementation
- Ferrous sulfate, ferrous gluconate, ferrous fumarate
* 3-6 mg/kg/day in 1 or 2 doses
* Empty stomach with Vitamin C
* DO NOT GIVE WITH CALCIUM (milk formula or iron-fortified cereal)
* Side effects = teeth staining (use straw); dark stools; constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sickle Cell Disease (SCD)

* Genetic disorder = autosomal ___ condition

* Affects African, Mediterranean, Indian, and Middle Eastern descent

* Group of hemoglobinopathies characterized by production of sickle hemoglobin, chronic hemolytic anemia, ischemic tissue injury

A

recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Caused by:

* Low O2 concentration
* Acidosis
* Dehydration
* Stress

Which in children with SCD leads to RBCs assuming sickle shape
> Lifespan 10-20 days as opposed to 100-120 days
> Clumping together causes occlusions in small and large vessels
- Tissue ischemia, infarct, organ damage
- Lungs, spleen, and brain most affected

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sickle Cell Disease (SCD) - Manifestations

__ __ __
> Anemia, pallor, jaundice, fatigue, cholelithiasis, delayed growth in puberty, avascular necrosis of the hips and shoulders, renal dysfunction and retinopathy

Acute exacerbations or __ __ __
> Triggered by infection, dehydration, hypoxia, trauma, stress

A

Chronic hemolytic anemia

SICKLE CELL CRISIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sickle Cell Disease (SCD)

Complication of SCD = Sickle Cell Crisis can be…

?

* Increased destruction or decreased production of RBCs

* Pallor, lethargy, headache, syncope

* Tx - RBCs transfusions

A

Aplastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

?

* Most common PAIN
> Bone and joint pain

* Less common
> Acute chest syndrome, dactylitis, priapism, CVA

* Treatment
> oral analgesics
> oral and IV opioids, NSAIDs, hydration
> aggressive incentive spirometry (10x q2 hrs while awake)

A

Vaso-occlusive

17
Q

?

* Obstructed blood flow from organs = engorged organs

  • Engorged liver and spleen
  • Pallor, irritability, and tachycardia
  • ↓ Hgb
  • Hypovolemic shock

* Leads to acute anemia

* When in lungs leads to acute chest syndrome
> s/s - chest pain, fever, cough, abd pain
> Tx - IV hydration, antibiotics, O2, RBC transfusion, analgesics

* Treatment in general
> IV fluid with crystalloid and colloid infusion
> Transfusion TX
> Splenectomy

A

Acute Sequestration

18
Q

Sickle Cell Disease (SCD) - Therapeutic Management

* Preventing infections
> Prophylactic daily penicillin V therapy (BID) until age 5

* Immunizations
> Pneumococcal polyvalent vaccine PCV-13 (ages 2-4-6 and 12-15 months)
> H-influenzae
> Hepatitis B (birth - 2 mos - 4 mos)
> Annual influenza vaccine
> Meningococcal vaccine after age 2

A

* Preventing exacerbations

* Pain management
> Opioids (morphine is opioid of choice) and NSAIDs

* Identify complications
> Assess for fever - prompt tx if > 101.3
> Prevent strokes
> Avoid extreme cold/extreme heat

* Supportive care
> Hydration
> Oxygenation
> Analgesia
> RBC transfusion

19
Q

Thalassemia

* Genetic disorder

* Thalassemia minor = 1 parent inherited gene

* Thalassemia major = 2 parent inherited genes = severe

* Primarily Mediterranean, Asian, African American descent

A

* Reduction or abnormal Hgb

↓ circulating O2

Triggers production of erythrocytes ⇒

To meet demands - extramedullary hematopoiesis ⇒

Chronic state of production and destruction of erythrocytes ⇒

Inadequate amount of normal Hgb

20
Q

Beta-thalassemia Manifestations

  • Pallor
  • Growth retardation
  • Pubertal delay
  • Severe anemia
  • Characteristics facies (enlarged head, frontal and parietal bossing, severe maxillary hyperplasia, wide-set eyes with a flattened nose, malocclusion)
  • Hepatosplenomegaly
  • Bronze skin tone (yellow/green)
A

Diagnostic evaluation

  • CBC
  • Microcytic, hypochromic anemia
21
Q

Therapeutic Management - Beta Thalassemia

* Erythrocyte transfusions - packed RBCs
> Goal to maintain Hgb at __ g/dL

* Chelation therapy
- Iron builds up from byproduct of hemolysis of RBCs
- Iron builds up from transfusions
> Inability for intestines to absorb large quantities of Fe
> ___ - excess deposits of Fe in tissues (major complication of long-term transfusion therapy)

CHELATION Therapy - removes excess amounts of Fe
> Deferoxamine (Desferal), Deferasirox (Exjade)

* Splenectomy

* Bone marrow transplant/stem cell transplant (only cure)

A

11 g/dL

HEMOSIDEROSIS

22
Q

Hemophilia

* Hereditary - X-linked autosomal __ disorder (no cure)

* Female carriers pass onto males

* Lack of coagulation “factor”

* Varies - % in blood

> Hemophilia A - lack factor ___ (classic)

> Hemophilia B - lack factor ___ (Christmas disease)

> Hemophilia C - lack factor ___ (mild)

A

recessive

VIII

IX

XI

23
Q

Hemophilia - Manifestations

* Bleeding
- After surgery or serious trauma

* Easily bruising

* Episodes of epistaxis and hematuria

* Bleeding in muscles and joints - ___

  • Especially knees
  • Causes swelling, pain, bleeding, stiffness
A

hemarthrosis

24
Q

Hemophilia - Therapeutic Management

* Individualized and depends on severity

Goal ⇒ Prevent excessive bleeding and tissue damage by supplying the body with the missing factors - VIII or IX

* Monoclonal products

* Prophylactic therapy
> For mild hemophilia A - desmopressin acetate (DDAVP) intranasal spray - vasoconstrictor action

* Prophylactic factor - prior to surgery or dental procedures

A

* Prevent injury
> Pad corners, cribs, and extra padding for bones
> Soft brittle toothbrushes
> Avoid contact sports
> Protective helmets

* Injury
> Monitor area of injury qh/24 hours
> Measure circumference
> Head trauma = LOC hourly
> Treat = RICE
> Apply gentle pressure 10-15 min (venipunctures)

* Avoid rectal temps

* Administer factor replacement

* Do not give acetylsalicylic acid (aspirin or aspirin-containing products)

25
Q

?

  • Most common inherited bleeding disorder
  • Autosomal inherited disorder with dominant and recessive variants

Type __ (defect in __ __ factor)

Type __ (mild-moderate)

A

Von Willebrand Disease

* Underproduction or dysfunction of Von Willebrand protein

II (Von Willebrand)

I

26
Q

Von Willebrand Disease - Manifestations

* Epistaxis
* Bleeding from the gums
* Prolonged bleeding from cuts
* Excessive bleeding after surgery or trauma
* Menorrhagia (excessive menstrual bleeding)

Diagnostic evaluation

  • Family history
  • Bleeding history
  • Lab tests - bleeding time, clotting time (PT)
  • ELIZA
A

Von Willebrand Disease - Therapeutic Management

Goal is to control bleeding episodes and replace missing or dysfunctional factor in the blood

* Transfusion of anti-hemolytic factors or FFP
* Treatment of choices - DDAVP - synthetic derivative of ADH vasopressin

* Adolescent females with menorrhagia -
> Anti-fibrinolytics -
- Oral aminocaproic acid (Amicar) or tranexamic acid (Lysteda)

Education

  • Prophylactic therapy
  • Medic alert bracelet
  • Limit contact sports
  • Avoid OTC ASA, NSAIDs
27
Q

Immune Thrombocytopenic Purpura (ITP)

* Acquired bleeding disorder

* Characterized by thrombocytopenia due to immune destruction (platelets <150,000 mm3); purpura rash; normal bone marrow production

* Acute or chronic

* Etiology - unknown

* Autoimmune - antibodies attack platelets and destroy (macrophages) in liver and spleen

A

Manifestations
- Sudden onset of bruising and petechiae (mucous membranes and gums)

Diagnostic evaluation
- Family history
- CBC
> Low platelet count <50,000 mm3
- Physical exam - bruising and petechiae
- Bone marrow aspirate - rule out cancer

28
Q

Therapeutic management

* Goal is to prevent real life-threatening bleeding disorders such as intracranial bleeding

  • Restore platelet count above 20,000
  • Oral steroids and IV immunoglobulin (IVIG)
  • Splenectomy
A

Family education

  • Maintaining IV access for IV steroids or IVIG
  • Restricting activity
  • Use extra soft bristle toothbrush if platelet count <20,000
  • Educating on side effects of steroids - mask infection
  • Avoid administering IM injections; aspirin-containing products; and taking temperatures rectally
29
Q

?

* Acquired hemorrhagic syndrome

Characterized by uncontrolled formation in deposition of fibrin thrombi

Causes

  • trauma
  • hypoxemia
  • necrotizing enterocolitis
  • shock
  • liver disease
  • overwhelming viral or bacterial infections
  • acute promyelocytic leukemia
A

Disseminated Intravascular Coagulation (DIC)

30
Q

Disseminated Intravascular Coagulation (DIC) - Manifestations

  • Changes in platelet count and fibrinogen levels
  • Excessive bruising and petechiae
  • Oozing from puncture sites
  • Oozing from sites of mild tissue damage
  • Mild GI bleeding
A

Disseminated Intravascular Coagulation (DIC) - As disease progresses:

  • purpuric rash
  • worsening of bleeding
  • hemoptysis
  • hypoxemia
  • oliguria
  • renal failure
  • organ failure
  • intracranial bleeding
31
Q

Disseminated Intravascular Coagulation (DIC) - Diagnostic evaluation

* Decreased RBC count

* Low platelet count

* RBC fragments on smear

* Prolonged PT

* Decreased fibrinogen level

* Elevated levels of fibrin degradation products (fdps) and D-dimer

A

Disseminated Intravascular Coagulation (DIC) - Therapeutic management

Goal is to identify and treat underlying conditions then treat symptoms

* Directed at replenishing consumed coagulation factors

  • FFP
  • RBCs and platelet transfusions
  • Vitamin K
  • Heparin
32
Q

Aplastic Anemia

Characterized by cessation of hematopoiesis = granulocytes, erythrocytes, and megakaryocytes

⇒ peripheral pancytopenia

↓ WBC ↓ RBC ↓ Platelets

* Etiology = congenital, acquired, or idiopathic
* Mild, moderate, severe (depends on counts)

A

Diagnosis of severe aplastic anemia requires 2 of the following:

  • granulocyte count <500 mm3
  • platelet count <20,000 mm3
  • reticulocyte count below 1%
  • Also, bone marrow biopsy specimen must contain <25% of the normal cellularity
33
Q

Aplastic Anemia - Manifestations

* Petechiae
* Ecchymosis

* Pallor
* Epistaxis

* Fatigue
* Tachycardia
* Anorexia
* Infection

A

Aplastic Anemia - Therapeutic management

* Treat symptoms
* Platelet and erythrocyte transfusions
* Antibiotic therapies and blood cultures
* Immunosuppressive medication - cyclosporin and antithymocyte globulin (ATG)
* Bone marrow or stem cell transplantation

* Private room preferably
* Meticulous hand hygiene
* No injections
* No rectal temperatures, medications, or examinations
* Extra soft bristle toothbrush
* Abstain from any contact sports
* Platelet count maintained > 20,000 mm3
* Hemoglobin level maintained > 7 g/dL